Publications for William H. Frishman william_frishman@nymc.edu
Benson, M. M., & Frishman, W. H. (2015). The heartbreak of psoriasis: A review of cardiovascular risk in patients with psoriasis. Cardiology in Review, 23(6), 312-316. doi:10.1097/CRD.0000000000000048
Frishman, W. H. (2015). Can clinicians improve on the effectiveness of statins with additional lipid-lowering therapies? The American Journal of Medicine, 128(11), 1160-1161. doi:10.1016/j.amjmed.2015.06.027
Frishman, W. H. (2015). Is the stethoscope becoming an outdated diagnostic tool? The American Journal of Medicine, 128(7), 668-669. doi:10.1016/j.amjmed.2015.01.042
Frishman, W. H. (2015). Pharmacists in primary care. The American Journal of Medicine, 128(5), 443-444. doi:10.1016/j.amjmed.2014.11.021
Glicklich, D., & Frishman, W. H. (2015). Drug therapy of apparent treatment-resistant hypertension: Focus on mineralocorticoid receptor antagonists. Drugs, 75(5), 473-485. doi:10.1007/s40265-015-0372-3
Gupta, T., Harikrishnan, P., Kolte, D., Khera, S., Aronow, W. S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Lanier, G. M., Cooper, H. A., Frishman, W. H.,. . . & Panza, J. A. (2015). Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. The American Journal of Medicine, 128(8), 879-887.e1. doi:10.1016/j.amjmed.2015.02.025
Gupta, T., Harikrishnan, P., Kolte, D., Khera, S., Subramanian, K. S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Lanier, G. M., Cooper, H. A., Frishman, W. H., Panza, J. A., . . . Aronow, W. S. (2015). Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. The American Journal of Cardiology, 115(8), 1033-1041. doi:10.1016/j.amjcard.2015.01.529
Gupta, T., Khera, S., Kolte, D., Aronow, W. S., Fallon, J. T., Frishman, W. H., . . . Gass, A. (2015). Back from the brink: Catastrophic antiphospholipid syndrome. The American Journal of Medicine, 128(6), 574-577.
Gupta, T., Kolte, D., Harikrishnan, P., Khera, S.+, Aronow, W. S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Cooper, H. A., Frishman, W. H., . . . Panza, J. A. (2015). Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. Journal of the American Heart Association, 4(6), [Article e002069]. doi:10.1161/JAHA.115.002069
Harikrishnan, P., Palaniswamy, C., Kolte, D., Khera, S., Mujib, M., Aronow, W. S., Sule, S., Jain, D., Cooper, H. A., Jacobson, J., Iwai, S., Frishman, W. H., . . . Panza, J. A. (2015). Complete heart block complicating ST-segment elevation myocardial infarction temporal trends and association with in-hospital outcomes. JACC: Clinical Electrophysiology, 1(6), 529-538. doi:10.1016/j.jacep.2015.08.007
Khera, S., Kolte, D., Subramanian, K. S., Aronow, W. S., Cooper, H. A., Frishman, W. H., . . . Panza, J. A.(2015). Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States. Journal of the American College of Cardiology, 66(18), 1961-1972. doi:10.1016/j.jacc.2015.08.865
Kolte, D., Khera, S., Aronow, W. S., Palaniswamy, C., Mujib, M., Iwai, S., Jain, D., Sule, S., Cooper, H. A., Frishman, W. H., . . . Panza, J. A. (2015). Regional variation in the incidence and outcomes of in-hospital cardiac arrest in the United States. Circulation, 131(16), 1415-1425. doi:10.1161/CIRCULATIONAHA.114.014542
Kosmas, C. E., & Frishman, W. H. (2015). New and emerging LDL cholesterol-lowering drugs. American Journal of Therapeutics, 22(3), 234-241. doi:10.1097/MJT.0000000000000063
Liu, Y., Carrey, Z., Aronow, W. S., Alaie, D., Petrillo, R. L., & Frishman, W. H. (2015). The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in postangioplasty restenosis. American Journal of Therapeutics, 22(4), e107-e114. doi:10.1097/MJT.0b013e3182979b59
Pashun, R. A., & Frishman, W. H. (2015). Therapeutic role of innovative anti-inflammatory medications in the prevention of acute coronary syndrome. Cardiology in Review, 23(5), 252-260. doi:10.1097/CRD.0000000000000062
Segraves, J. M., & Frishman, W. H. (2015). Highly sensitive cardiac troponin assays: A comprehensive review of their clinical utility. Cardiology in Review, 23(6), 282-289. doi:10.1097/CRD.0000000000000087
Weinreich, M. A., Kafer, I., Tahara, D., & Frishman, W. H. (2015). Participants in a medical student-run clinic and career choice. Journal of Contemporary Medical Education, 3(1), 6-13. doi:10.5455/jcme.20150321111913
Barkin, J. S., Phillips, B. A., Berney, S. M., Garrick, R. Snydman, D. R., Frishman, W. H., . . . Loehrer Sr. P. J. (Eds.). (2014). Year book of medicine 2014. Elsevier.
Bosch, N., & Frishman, W. H. (2014). Newer therapeutic strategies to alter high-density lipoprotein level and function. Cardiology in Review, 22(1), 17-24. doi:10.1097/CRD.0b013e31829cac29
Coburn, E., & Frishman, W. (2014). Comprehensive review of the prognostic value of galectin-3 in heart failure. Cardiology in Review, 22(4), 171-175. doi:10.1097/CRD.0000000000000013
Doshi, J. V., Agrawal, S., Garg, J., Paudel, R., Palaniswamy, C., Doshi, T. V., . . . Frishman, W. H. (2014). Percutaneous mitral heart valve repair - MitraClip. Cardiology in Review, 22(6), 289-296. doi:10.1097/CRD.0000000000000036
Frishman, W. H., & Glicklich, D. (2014). The role of nonpharmacologic device interventions in the management of drug-resistant hypertension. Current Atherosclerosis Reports, 16(5), 405. doi:10.1007/s11883-014-0405-5
Glasser, S. P., & Frishman, W. H. (2014). The placebo and nocebo effect. In S. P. Glasser (Ed.), Essentials of clinical research (2nd ed., pp. 145-176). Switzerland: Springer International.
Gulati, V., Harikrishnan, P., Palaniswamy, C., Aronow, W. S., Jain, D., & Frishman, W. H. (2014). Cardiac involvement in hemochromatosis. Cardiology in Review, 22(2), 56-68. doi:10.1097/CRD.0b013e3182a67805
Gupta, T., Garg, J., Sharma, M., Khera, S., Aronow, W. S., Frishman, W. H., . . . Lanier, G. M. (2014). A rare concurrence: Nonischemic cardiomyopathy and multiple myeloma without amyloidosis. The American Journal of Medicine, 127(11), 1063-1066. doi:10.1016/j.amjmed.2014.07.012
